4//SEC Filing
Bamforth John Philip 4
Accession 0001818382-24-000132
CIK 0001818382other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:11 PM ET
Size
5.4 KB
Accession
0001818382-24-000132
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Bamforth John Philip
Director
Transactions
- Award
Stock Options (right to buy)
2024-06-13+75,000→ 75,000 totalExercise: $7.20Exp: 2034-06-13→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The first 25% of the option becomes exercisable on June 13, 2025, after which 1/48 of the option will become exercisable on the 13th of each month through June 13, 2028.
Documents
Issuer
Humacyte, Inc.
CIK 0001818382
Entity typeother
Related Parties
1- filerCIK 0002026341
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:11 PM ET
- Size
- 5.4 KB